Athena Global Technologies Subsidiary MedleyMed Enters the Global Market with a Suite of Digital Solutions for Both Pharmacy and Patient Care

Hyderabad | Friday | 24th September, 2021

Summary:

Hyderabad, Telangana, India – Business Wire India • MedleyMed (www.medleymed.com) to strengthen Athena Global Technologies (a BSE listed firm) Strategic Business Expansion Plans • MedleyMed to launch exclusive epharmacy and telemedicine services by the end of 2021 • Offline pharmacy presence through a franchisee network under MedleyMed brand MedleyMed, a subsidiary of Athena Global Technologies Ltd (BSE: 517429, ATHENAGLO), has entered U.S.

and other global markets with a suite of digital health solutions for both pharmacy businesses and patient care.

The company which is present in the niche segment is also expanding its operations within India and has strong plans to launch its exclusive epharmacy and telemedicine services by the end of 2021 and offline pharmacy presence through a franchisee network under MedleyMed brand.

MedleyMed offers end-to-end digital health products and solutions, keeping in mind the digital requirements of every stakeholder in the pharma and healthcare ecosystem.

It provides varied solutions that are customisable to any specific content and workflow and Plug and Play Solutions that can integrate with existing software, thus providing superior customer–patient engagement.

• B2B, B2C solutions and telemedicine platform enables both consumers and pharmacies to purchase pharmaceuticals/ medicines at the lowest price • SaaS based Tele medicine Platform to hospital • SaaS based ERP and POS platform to medical stores • Business model easily scalable to international markets Since the outbreak of coronavirus disease (COVID-19), globally the demand for digital healthcare products and solutions has increased tremendously.